Moderna(us:MRNA)

28.35

-8.90%

Updated on 2025-03-31

Open:28.89
Close:28.35
High:28.95
Low:26.80
Prev Close:31.12
Volume:20.41M
Turnover:569.86M
Turnover Ratio:5.28%
Shares:386.62M
MarketCap:10.96B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3097826193234268.21%121323359
2024-03-3194225933335267.71%108317361
2023-12-3197125712721567.31%125265456
2023-09-3099524364890764.02%78348431
2023-06-30104124544811364.39%71296486
2023-03-31109826868886370.05%104316507
2022-12-31109924781600464.37%232291423
2022-09-30100324244915962.65%74296464
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Baillie Gifford & Co4344904111.31%-1206776-2.70%
2024-06-30Vanguard Group Inc3956279610.30%5259241.35%
2024-06-30Blackrock Inc.255623216.66%1664430.66%
2024-06-30Fmr Llc211612855.51%756144855.60%
2024-06-30State Street Corp150239363.91%5719013.96%
2024-06-30Theleme Partners Llp72268611.88%-94936-1.30%
2024-06-30Geode Capital Management, Llc68914651.79%1409862.09%
2024-06-30Morgan Stanley50065201.30%-487445-8.87%
2024-06-30Flagship Pioneering Inc.46321491.21%-5033889-52.08%
2024-06-30Wellington Management Group Llp43185711.12%-1286132-22.95%

About

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Address:325 Binney Street

Market Movers